Trials / Completed
CompletedNCT04210128
Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment
Continuous Glucose Monitoring For Prediction and Treatment of Steroid-Induced Hyperglycemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if continuous glucose monitoring can identify how often people who have pre-diabetes or medical obesity or well-controlled diabetes experience very high glucose values while receiving chemotherapy for breast cancer or pancreatic.
Conditions
Timeline
- Start date
- 2019-12-20
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2019-12-24
- Last updated
- 2023-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04210128. Inclusion in this directory is not an endorsement.